hae

Ua hoʻonui ka ʻoihana biopharmaceutical o Kina i kona piʻi ʻana i "ikaika hoʻokele hou" no ka ulu mau.

I loko o ka hale hana hana biopharmaceutical hou o Qilu Pharmaceutical Group Co., Ltd. aia ma Jinan, Shandong, ʻo ka lāʻau biosimilar biosimilar bevacizumab mua o koʻu ʻāina, ʻo Anke, i ka hana piha.ʻO kēia lāʻau lapaʻau, ka mea i hoʻohana nui ʻia no ka mālama ʻana i ka maʻi maʻi maʻi ʻaʻai nui, metastatic a i ʻole e hoʻi hou ana i ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi a me ka maʻi maʻi colorectal metastatic, ua hoʻokuʻu ʻia i ka hopena o ka makahiki i hala, e uhaʻi ana i ka monopoly kūʻokoʻa o nā ʻano lāʻau lapaʻau haole ma nā lāʻau like ma Kina no nā makahiki he nui, hoʻonui nui i ka hoʻohana lāʻau lapaʻau.ʻO ka hiki a me ka hiki ke loaʻa.

E like me kekahi o nā ʻoihana alakaʻi i ka ʻoihana lāʻau lapaʻau o koʻu ʻāina, ua loaʻa ʻo Qilu Pharmaceutical i nā loaʻa kūʻai kūʻai o 23 biliona yuan ma 2019 a me nā hoʻoiho o 615 miliona mau kālā US;i nā mahina 11 mua o 2020, ua hoʻonui ʻia kāna huahana huahana e 14% makahiki-ma-makahiki.I kēia manawa, ua lawe ʻia aku nā huahana lāʻau lapaʻau Qilu ma mua o 70 mau ʻāina a me nā wahi a puni ka honua.

ʻO ka ʻoihana biopharmaceutical kekahi o nā ʻoihana hoʻolālā hou a lōʻihi loa i ka 21st century.ʻOiai ua hoʻomaka lohi koʻu ʻāina i kēia kahua, ua ulu wikiwiki ia.ʻOi loa i ka pōʻaiapili o ka maʻi maʻi pneumonia lei aliʻi hou a puni ka honua, ʻo ke kaulahao ʻoihana piha a me ka mana hoʻolako ikaika o ka ʻoihana biopharmaceutical o Kina ʻaʻole i hāʻawi wale i nā mea koʻikoʻi i ka hakakā honua e kūʻē i ka maʻi maʻi maʻi, akā ua lilo pū kekahi i "ikaika hoʻokele hou". no ka ulu mau ʻana i ka piʻi wikiwiki ʻana..

I nā lā mua o ka maʻi ahulau, ʻo nā masks, ma ke ʻano he huahana anti-epidemic pono, ua "paʻakikī ke loaʻa" i ka mākeke.Ua wehe ʻo Jinan City i ke kaulahao ʻoihana holoʻokoʻa o ka hana mask i hoʻokahi mahina, a ua hoʻonui ʻia ka hopena o kēlā me kēia lā mai 60,000 a ʻoi aku ma mua o 400 mau manawa, e hāʻawi ana i kahi hōʻoia ikaika no ka lanakila ʻana i ke kaua kūʻē i ka pale ʻana a me ka hoʻomalu ʻana.

ʻO kahi "pae ho'āʻo" maikaʻi kekahi o nā "mea kaua kilokilo" e hōʻemi pono i ka hopena o ka hoʻolaha ʻana o ka maʻi maʻi.I ka hoʻomaka ʻana o Pepeluali 2020, ua lilo koke ʻo Jinan Yinfeng Medical Laboratory (Yinfeng Gene Technology Co., Ltd.), kahi ʻāpana o Yinfeng Bioengineering Group Co., Ltd., i ke kolu o ka hui mua no ka ʻike nucleic acid o ka coronavirus hou ma Jinan.ʻO kāna pahu lei aliʻi hou i hoʻomohala ʻia ua hala i ka palapala EU CE;hiki ke ho'āʻo i ka awelika o 20,000 mau laʻana i kēlā me kēia lā ka hale kaʻa kaʻa kaʻa kaʻa 5G mobile nucleic acid ma Shandong Province.

Ma lalo o ka hopena o ka maʻi maʻi, ua hana ka nui o nā ʻoihana i ka wā e hoʻonui ai i ka hana o nā masks, nā lole pale, nā ventilator a me nā mea anti-epidemic ʻē aʻe, i hāʻawi mau ʻia i nā laina mua o ka anti-epidemic ma ka home a ma waho.Ma ke ʻano he ʻoihana ʻenehana kiʻekiʻe kiʻekiʻe o ka mokuʻāina, ua hana wikiwiki ʻo Shandong Broke Biological Industry Co., Ltd. a hoʻouna ʻoi aku ma mua o 5,000 biosafety lako, huahana disinfection ea, sterilizers a me nā huahana ʻē aʻe i loko o nā mahina wale nō.

Mai ka puka ʻana mai o ka maʻi ahulau, ua hoʻolako ikaika koʻu ʻāina i nā mea anti-epidemic i ka honua.Aia ma mua o 200 biliona masks wale nō, a i ʻole 30 per kapita ma ka honua.Wahi a ka ʻikepili i hoʻokuʻu ʻia e ka General Administration of Customs, i nā hapaha mua ʻekolu o 2020, ua hoʻomau ka ulu wikiwiki ʻana o Kina i nā mea anti-epidemic.I waena o lākou, ʻo ka hoʻokuʻu ʻana i nā textiles me nā masks he 828.78 biliona yuan, kahi hoʻonui o 37.5%.Eia kekahi, ua hoʻonui ʻia ka lawe ʻana aku i nā lāʻau lapaʻau a me nā lāʻau lapaʻau, nā mea lapaʻau a me nā mea hana e 21.8% a me 48.2%.

ʻO ka lawe ʻana aku i nā huahana hoʻomākaukau kiʻekiʻe i nā ʻāina ʻEulopa a me ʻAmelika he hōʻike ia o ka ikaika piha o nā ʻoihana biopharmaceutical o koʻu ʻāina.ʻO Li Yan, Pelekikena o Qilu Pharmaceutical Group Co., Ltd., ua hoʻolauna ʻia i kēia manawa 15 mau lāʻau lapaʻau pilikino o Qilu Pharmaceutical i lawe ʻia aku i ʻAmelika Hui Pū ʻIa, a me ka cefepime no ka injection, ondansetron hydrochloride injection, a me nā papa solifenacin e noho i ka māhele mua ma ka mākeke. ʻAmelika Hui Pū ʻIa;ʻO ia ka manawa mua loa ma Kina Ua lawe ʻia aku i nā injections hoʻopuka pāʻoihana i Iapana;Ua lawe ʻia aku nā huahana 9 i ka mākeke ʻEulopa.

Hoʻohana nui ʻia ka hyaluronic acid (i kapa ʻia ʻo "hyaluronic acid") i nā orthopedics, ophthalmology, ʻokiʻoki nui, ʻokiʻoki a me nā ʻano lāʻau lapaʻau a me nā mea lapaʻau, nā mea hoʻonaninani a me nā meaʻai olakino.Ua ʻōlelo ʻo Zhao Yan, ka luna o Bloomage Biotechnology Co., Ltd., i ka hilinaʻi ʻana i ka hana hou kūʻokoʻa, ua alakaʻi ʻo Bloomage Bio i ka ʻike ʻana i kahi holomua i ka hana ʻenehana o ka hyaluronic acid microbial fermentation ʻenehana i Kina, ka mea i hoʻololi i ka hana ʻana o ka hyaluronic acid e nā holoholona. ka ʻili ʻana o ka ʻiʻo a me ka hilinaʻi nui ʻana i ka unuhi ʻana o ka ʻiʻo holoholona.Ma muli o ka backwardness o imports, ua hiki i ka mua o ka honua i loko o ke kahua o ka hyaluronic acid, a me kona kūʻai aku i kēia manawa uhi 'oi aku ma mua o 40 aina a me nā māhele'āina.

"He hōʻailona koʻikoʻi nā lāʻau lapaʻau hou e ana i ka mana hou a me ka ikaika o nā ʻoihana, a he wahi hoʻomaka koʻikoʻi e hāpai i nā hui lāʻau lapaʻau Kina e lanakila i ka hoʻokūkū honua a hoʻokō mai ka 'follow' a hiki i ka 'holo' a me ka 'alakaʻi' i ka wā e hiki mai ana.Ua ʻōlelo ʻo Qilu Institute of Innovative Medicines Zhu Yidong, ka luna pelekikena hoʻokō.

He 7 mau makahiki no Qilu Pharma e hoʻomohala maikaʻi i nā papa gefitinib (Ireco), he lāʻau lapaʻau kūikawā no ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi.Ma mua o 3 mau makahiki mai kona hoʻomaka ʻana, ua hoʻemi ʻia ke kumukūʻai o nā lāʻau like ʻole i lawe ʻia mai ka 5,000 yuan ma ka pahu i ʻoi aku ma mua o 500 yuan;I nā makahiki he 10 i hala iho nei, ua holomua ka hoʻomohala ʻana o nā biosimilars bevacizumab, a ua hāʻule nui hoʻi ke kumukūʻai o ka lāʻau ma hope o ka hoʻokuʻu ʻana.

Hōʻike ʻia e Qilu Pharmaceutical, Bloomage Bio, a me nā mea ʻē aʻe, aia ʻo Shandong i kēia manawa he mau ʻoihana alakaʻi i ke kahua o ka biomedicine.I kēia manawa, loaʻa iā Shandong he 21 mau papa hana hou lāʻau lapaʻau, 5 mau keʻena noiʻi loiloi palekana palekana, a me 61 mau keʻena hoʻokolohua lāʻau lapaʻau.ʻO ka pālākiō o ka ʻoihana lāʻau lapaʻau he hoʻokahi hapahiku o ka huina o ka ʻāina.

I ka manawa like, ua hoʻokumu ʻia nā hui ʻoihana biopharmaceutical ma nā wahi he nui o koʻu ʻāina.I ka makahiki 2019, ua ʻoi aku ka nui o ka ʻoihana lapaʻau a me ka ʻoihana olakino ma Beijing ma mua o 200 biliona yuan, e mālama ana i ka ulu pālua ʻelua no ʻehā mau makahiki;ʻO Jiangsu lāua ʻo Suzhou i kēia manawa he 3,000 mau ʻoihana biopharmaceutical me kahi kokoke i 50,000 mau limahana pili.I nā hapaha mua ʻekolu o 2020, biopharmaceuticals Ua loaʻa i ka ʻoihana ka loaʻa kālā ma kahi o 170 biliona yuan, kahi hoʻonui makahiki ma kahi o 24%.Manaʻo ʻia e ʻoi aku ka loaʻa kālā makahiki ma mua o 200 biliona yuan.

"ʻO ka hoʻonui ʻana i ka noiʻi a me ka hoʻomohala ʻana i nā lāʻau hou e hoʻomau i ka hoʻokomo ʻana i ka manawa hou i ka hoʻomohala kiʻekiʻe o ka ʻoihana biopharmaceutical o koʻu ʻāina," wahi a Bao Haizhong, hope pelekikena o Qilu Pharmaceutical Group.Hoʻopili pono ʻo Qilu Pharmaceutical i ke ʻano hoʻomohala o nā lāʻau lapaʻau hou honua.I kēia manawa, ʻoi aku ma mua o 50 mau papahana lāʻau lapaʻau hou i lalo o ka hoʻomohala ʻana, a ʻoi aku ma mua o 10 i ʻae ʻia no nā hoʻokolohua lapaʻau.Ma 2020, e noi ʻia nā papahana 11 no IND (nā hoʻokolohua lāʻau lapaʻau hou) ma Kina a me ʻAmelika Hui Pū ʻIa.

ʻO ka "2020 China Life Science and Biotechnology Development Report" i hoʻokuʻu ʻia ma Nowemapa 2020 i hōʻike ʻia mai ka makahiki 2010, ʻo ka nui o nā noi patent ma Kina i mālama i ka lua o ka honua, a ʻo ka helu o nā mana patent ma 2019 i helu mua i ka honua. .ʻO ka biotechnology a me ka noiʻi lāʻau lapaʻau hou a me ka hoʻomohala ʻana ʻelua mau wahi nui o ka hopohopo no ke kapikala.ʻO Kina ka lua o ka nui o ka hoʻopukapuka kālā a me ka ʻāina koʻikoʻi kālā ma ka honua ma hope o ʻAmelika Hui Pū ʻIa.

Wahi a Tan Yong, Hope Pelekikena o China Pharmaceutical Enterprise Management Association, ua ulu wikiwiki ka hāʻawi ʻana o Kina i ka hana hou lāʻau lapaʻau honua i nā makahiki i hala.Ke hoʻomau nei kahi pūʻulu o nā hui biopharmaceutical i nā hana i ka noiʻi kumu a hoʻonui i ka mākeke honua.Nā ʻanuʻu i ka echelon mua o ka hana hou lāʻau lapaʻau honua.


Ka manawa kau: Apr-01-2022